The objective of this study was to determine whether there are differential impacts on maternal serum and cord blood levels of adiponectin, leptin and insulin at delivery based upon the duration of diabetes during pregnancy (GDM versus pre-existing T2D) and whether these levels are associated with fetal growth and birthweight. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.